Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

• Hauptverfasser: Andrea Miró-Canturri (VerfasserIn), Rafael Ayerbe-Algaba (VerfasserIn), Andrea Vila-Domínguez (VerfasserIn), Manuel E. Jiménez-Mejías (VerfasserIn), Jerónimo Pachón (VerfasserIn), Younes Smani (VerfasserIn)
• Format: Buch
• Veröffentlicht: MDPI AG, 2021-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

The development of new strategic antimicrobial therapeutic approaches, such as drug repurposing, has become an urgent need. Previously, we reported that tamoxifen presents therapeutic efficacy against multidrug-resistant (MDR) <i>Acinetobacter baumannii</i>, <i>Pseudomonas aerugino...